Related Articles
Prospective evaluation of fluorescence in situ hybridization for diagnosing urothelial carcinoma
Diagnosis of bladder cancer from the voided urine specimens using multi‑target fluorescence in situ hybridization
Low level STK15 amplification in histologically benign urothelium of patients with bladder cancer adversely predicts patient outcome following cystectomy
Telomerase activity in bladder cancer, bladder washings and in urine
A gene‑expression‑based test can outperform bap1 and p16 analyses in the differential diagnosis of pleural mesothelial proliferations